Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

GC-MS Based Plasma Metabolomics for Identification of Candidate Biomarkers for Hepatocellular Carcinoma in Egyptian Cohort
Mohammad Ranjbar, Yue Luo, Cristina Di Poto, et al.
PLoS ONE (2015) Vol. 10, Iss. 6, pp. e0127299-e0127299
Open Access | Times Cited: 75

Showing 1-25 of 75 citing articles:

Branched Chain Amino Acids
Michael D. Neinast, Danielle Murashige, Zoltàn Arany
Annual Review of Physiology (2018) Vol. 81, Iss. 1, pp. 139-164
Open Access | Times Cited: 491
From sample treatment to biomarker discovery: A tutorial for untargeted metabolomics based on GC-(EI)-Q-MS
Annalaura Mastrangelo, Alessia Ferrarini, Fernanda Rey-Stolle, et al.
Analytica Chimica Acta (2015) Vol. 900, pp. 21-35
Closed Access | Times Cited: 164
GC–MS based metabolomics used for the identification of cancer volatile organic compounds as biomarkers
Giuseppe Lubes, Mohammad Goodarzi
Journal of Pharmaceutical and Biomedical Analysis (2017) Vol. 147, pp. 313-322
Closed Access | Times Cited: 133
Exploration of candidate biomarkers for human psoriasis based on gas chromatography-mass spectrometry serum metabolomics
Hongyan Kang, X. Li, Qian Zhou, et al.
British Journal of Dermatology (2016) Vol. 176, Iss. 3, pp. 713-722
Closed Access | Times Cited: 104
Applications of Metabolomics in Cancer Studies
Emily G. Armitage, Michał Ciborowski
Advances in experimental medicine and biology (2017), pp. 209-234
Closed Access | Times Cited: 92
Untargeted metabolomics as a diagnostic tool in NAFLD: discrimination of steatosis, steatohepatitis and cirrhosis
Mario Masarone, Jacopo Troisi, Andrea Aglitti, et al.
Metabolomics (2021) Vol. 17, Iss. 2
Closed Access | Times Cited: 57
The Emerging Role of Branched-Chain Amino Acids in Liver Diseases
Emily Kwun Kwan Lo, Felicianna, Jinghang Xu, et al.
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1444-1444
Open Access | Times Cited: 43
Metabolomics in hepatocellular carcinoma: From biomarker discovery to precision medicine
Xingyun Wu, Zihao Wang, Li Luo, et al.
Frontiers in Medical Technology (2023) Vol. 4
Open Access | Times Cited: 23
Metabolomic analysis of human cirrhosis, hepatocellular carcinoma, non-alcoholic fatty liver disease and non-alcoholic steatohepatitis diseases.
Akram Safaei, Afsaneh Arefi Oskouie, Seyed Reza Mohebbi, et al.
PubMed (2016) Vol. 9, Iss. 3, pp. 158-73
Closed Access | Times Cited: 74
Multiplatform plasma fingerprinting in cancer cachexia: a pilot observational and translational study
Mónica P. Cala, M. Teresa Agulló-Ortuño, Elena Prieto‐García, et al.
Journal of Cachexia Sarcopenia and Muscle (2018) Vol. 9, Iss. 2, pp. 348-357
Open Access | Times Cited: 72
Ceramide and polyunsaturated phospholipids are strongly reduced in human hepatocellular carcinoma
Sabrina Krautbauer, Elisabeth M. Meier, Lisa Rein‐Fischboeck, et al.
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2016) Vol. 1861, Iss. 11, pp. 1767-1774
Closed Access | Times Cited: 71
Role of lipids in pathophysiology, diagnosis and therapy of hepatocellular carcinoma
Christa Buechler, Charalampos Aslanidis
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2020) Vol. 1865, Iss. 5, pp. 158658-158658
Closed Access | Times Cited: 67
Comprehensive Metabolomic Search for Biomarkers to Differentiate Early Stage Hepatocellular Carcinoma from Cirrhosis
Da Jung Kim, Eun Ju Cho, Kyung‐Sang Yu, et al.
Cancers (2019) Vol. 11, Iss. 10, pp. 1497-1497
Open Access | Times Cited: 66
Role of Branched-chain Amino Acid Metabolism in Tumor Development and Progression
Min Kyu Jung, Akinkunmi Paul Okekunle, Jung Eun Lee, et al.
Journal of Cancer Prevention (2021) Vol. 26, Iss. 4, pp. 237-243
Open Access | Times Cited: 40
BCKDK of BCAA Catabolism Cross-talking With the MAPK Pathway Promotes Tumorigenesis of Colorectal Cancer
Peipei Xue, Fanfan Zeng, Qiuhong Duan, et al.
EBioMedicine (2017) Vol. 20, pp. 50-60
Open Access | Times Cited: 56
Deciphering hepatocellular carcinoma through metabolomics: from biomarker discovery to therapy evaluation
Wei Guo, Hor‐Yue Tan, Ning Wang, et al.
Cancer Management and Research (2018) Vol. Volume 10, pp. 715-734
Open Access | Times Cited: 50
Metabolomic estimation of the diagnosis of hepatocellular carcinoma based on ultrahigh performance liquid chromatography coupled with time-of-flight mass spectrometry
Yuanfeng Li, Shi Qiu, Lijuan Gao, et al.
RSC Advances (2018) Vol. 8, Iss. 17, pp. 9375-9382
Open Access | Times Cited: 49
Metabolomic Characterization of Hepatocellular Carcinoma in Patients with Liver Cirrhosis for Biomarker Discovery
Cristina Di Poto, Alessia Ferrarini, Yi Zhao, et al.
Cancer Epidemiology Biomarkers & Prevention (2016) Vol. 26, Iss. 5, pp. 675-683
Open Access | Times Cited: 47
The role of branched chain amino acids metabolic disorders in tumorigenesis and progression
Jingtong Wang, Wei Wang, Feng Zhu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113390-113390
Open Access | Times Cited: 26
Branched-Chain Amino Acids in Liver Diseases: Complexity and Controversy
Yaqi Zhang, Luqi Zhan, Lingjian Zhang, et al.
Nutrients (2024) Vol. 16, Iss. 12, pp. 1875-1875
Open Access | Times Cited: 4
Nuclear Magnetic Resonance metabolomics reveals an excretory metabolic signature of renal cell carcinoma
Márcia Monteiro, António S. Barros, Joana Pinto, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 44
Tissue and serum metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma
Jun Han, Wenxing Qin, Zhen‐li Li, et al.
Clinica Chimica Acta (2018) Vol. 488, pp. 68-75
Closed Access | Times Cited: 44
Recent Advances of Microbiome-Associated Metabolomics Profiling in Liver Disease: Principles, Mechanisms, and Applications
Raja Ganesan, Haripriya Gupta, Yoseph Asmelash Gebru, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 1160-1160
Open Access | Times Cited: 30
SLC13A3 is a major effector downstream of activated β-catenin in liver cancer pathogenesis
Wennan Zhao, Xue Wang, Lifeng Han, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Predicting human health from biofluid-based metabolomics using machine learning
Ethan D. Evans, Claire Duvallet, Nathaniel D. Chu, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 28
Page 1 - Next Page

Scroll to top